fda banned semaglutide bans compounded and tirzepatide ban on The End of Compounded Semaglutide: Why the FDA's Decision Matters for is fda stopping compounded tirzepatide – FDA Drug Recalls and Warnings:

Most importantly, when in doubt, ask your healthcare provider

For patients with type 2 diabetes, HbA1c levels are closely tracked to adjust any concurrent diabetes medications (like insulin or sulfonylureas) to prevent hypoglycemia

The fundamental difference is that Ozempic works through hormonal pathways with metabolic benefits, whilst phentermine acts as a central nervous system stimulant with cardiovascular effects

Risk-Benefit Decision Matrix How to use this matrix: If several of your personal factors place you in the Medium or High Priority columns, discussing a microdosing approach with a qualified clinician may be worthwhile